Chief Editor |
|
|
James D. Chalmers |
Professor James D. Chalmers is the Asthma and Lung UK Chair of Respiratory Research at the University of Dundee, Scotland and an honorary consultant physician at Ninewells Hospital. His clinical and research interests are in difficult respiratory infections, particularly bronchiectasis, COPD and COVID-19. He runs a translational research programme using mechanistic, translational and clinical approaches to develop new treatments for inflammatory lung disease. He is chair of the Science and Research Committee of the British Thoracic Society and is chair of the European Bronchiectasis Registry (EMBARC). He was appointed deputy chief editor of the ERJ in 2018 and was appointed Chief Editor in 2022. He has won a number of awards for research and teaching including the John Munro Medal for Teaching from the Royal College of Physicians of Edinbrgh (2014), the Romain Pauwels Award from the European Respiratory Society (2017), The Patrick Neil Medal from the Royal Society of Edinburgh (2017) and the Cournand Lecture Award from the European Respiratory Society (2021). E-mail: ERJEditors@ersnet.org |
Deputy Chief Editor |
|
|
Don D. Sin |
Don D. Sin, MD, is the Director of the Centre for Heart Lung Innovation (HLI), a Professor of Medicine at University of British Columbia (UBC) and a respirologist at St. Paul’s Hospital (SPH) in Vancouver, Canada. He holds a Tier 1 Canada Research Chair in COPD and the De Lazzari Family Chair at HLI. He has published more than 600 peer-reviewed papers and has an H-index of 110. E-mail: ERJEditors@ersnet.org |
Section Editors |
|
|
Stefano Aliberti |
Stefano Aliberti is Professor of Respiratory Medicine at Humanitas University and chief of the Respiratory Department at the Humanitas Research Hospital, Milan, Italy, where he also leads the bronchiectasis and non-tuberculous mycobacteria programmes. His major clinical and research interests are both acute and chronic respiratory infections. He has extensively published clinical and translational research papers on community-acquired pneumonia, especially in the field of clinical failure, cardiovascular events and antimicrobial resistance. He received the Young Researcher Award in Respiratory Infections from the European Respiratory Society for his contribution on community-acquired pneumonia. He currently chairs the ERS END-COVID CRC (The European Respiratory Network for Data-sharing in COVID-19). Over the past 15 years, he has been heavily involved in chronic respiratory infections, including bronchiectasis, cystic fibrosis, and non-tuberculous mycobacteria. He co-chairs the European Bronchiectasis Registry (EMBARC) and chairs both the Italian Bronchiectasis Registry and the Italian Registry of Pulmonary Non-Tuberculous Mycobacteria. Prof. Aliberti has published more than 350 peer-reviewed articles especially on respiratory infections over the past 20 years and he was part of different international task forces to produce guidelines on bronchiectasis, COVID-19 and severe pneumonia, as well as statements on tuberculosis. Prof. Aliberti was an Associate Editor at CHEST and Respirology. He has been heavily involved in different international societies over the past decade, including the European Respiratory Society, the American College of Chest Physicians, and the European Cystic Fibrosis Society, in different educational and scientific committees. |
|
Isabella Annesi-Maesano |
Prof. Isabella Annesi-Maesano (MD, PhD, DSc) is Deputy Director of the Institute Desbrest of Epidemiology and Public Health, a mixed INSERM and Montpellier University research unit in Montpellier (https://idesp.umontpellier.fr/en/accueil-english/). Presently, her research interests include the explanation of the etiopathogenesis of allergic and respiratory diseases and related comorbidities through an exposomic approach. Prof. Annesi-Maesano has served with various leadership positions in numerous international medical societies in the field of allergic and respiratory diseases (ERS, ATS, WAO, EAACI, Union), contributing to their Position and Recommendations Papers on air pollution, occupational hazards and climate change as well. Prof. Annesi-Maesano is the President of the Ethic Committee of the French Institute of Research and Development (IRD). She is also member of the ERS Ethic and Integrity committee and of the Ethical Advisory Board of the DARWIN EU(R) Coordination Centre (EMA). |
|
Mona Bafadhel |
Professor Mona Bafadhel is the Chair of Respiratory Medicine at King’s College London (KCL) and works in the School of Immunology and Microbial Sciences, part of the Faculty of Life Sciences and Medicine. Mona is also the Director of the new King’s Centre for Lung Health at KCL and Professor of Asthma+Lung UK. In 2012, Mona was awarded her PhD in ‘Biomarkers of exacerbations of Chronic Obstructive Pulmonary Disease (COPD)’. Mona is a clinical academic researcher and was awarded an NIHR postdoctoral fellowship between 2014-2018, which she held at the University of Oxford. In 2019, Mona was awarded the prestigious Gaulstonian Lectureship from the Royal College of Physicians, London. She is the fourth woman and first woman from an ethnic minority in the award's 350-year-old history to have received this for excellence in the Clinical Sciences. Mona has research interests in the field of airways disease, particularly the investigation of the mechanisms underlying exacerbations of COPD. This has led to studying the role of the eosinophil in COPD, using statistical approaches to define particular subgroups and to the delivery of novel therapeutic strategies to patients, working across the translational spectrum. Her work on the peripheral blood eosinophil in COPD has influenced international guidance and is now routinely used managing patients with COPD. |
|
Marc Humbert |
Marc Humbert, MD, PhD, is Professor of Respiratory Medicine, Vice Dean for Research and Director of the Inserm Unit 999 at the Université Paris-Saclay Medical School in Le Kremlin-Bicêtre, France, and President of the European Respiratory Society (2021/2022). He is the Director of the Department of Respiratory and Intensive Care Medicine, French Pulmonary Hypertension Reference Centre, Hôpital Bicêtre (Assistance Publique Hôpitaux de Paris). He is the vice-coordinator of the European Reference Network for rare and low prevalence respiratory diseases (ERN-LUNG). Marc was the Chief Editor of the European Respiratory Review and of the European Respiratory Journal where he is currently Section Editor in charge of pulmonary vascular medicine. Fellow of the ERS, he has received several international distinctions including the 2006 ERS Cournand Lecture and the 2018 ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension. Clarivate Analytics lists Marc Humbert as one of the world's highly cited researchers in the field of clinical medicine. |
|
Martin Kolb |
Martin Kolb, MD PhD, is the Jack Gauldie Boehringer Ingelheim Chair in Interstitial Lung Disease at McMaster University and the Firestone Institute for Respiratory Health in Hamilton, ON, Canada. His major interest is in interstitial lung disease and lung fibrosis, with an active research programme in mechanistic studies, translational and clinical science. He also provides clinical care in ILD and general respiratory medicine. Dr. Kolb was Associate Editor for Thorax and Deputy Editor for Respirology until 2018, before his appointment as Chief Editor for the ERJ from 2018 to 2022. |
|
Claudia E. Kuehni |
Claudia E. Kuehni, MD, MSc, is a Professor in Paediatric Epidemiology and Head of the Research Group Child and Adolescent Health at the Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland (www.ispm.unibe.ch). She has clinical training (FMH Board qualification) in paediatrics and paediatric pulmonology, and an MSc in epidemiology from the London School of Hygiene and Tropical Medicine. Her research groups host large population-based and clinical cohort studies and registries on respiratory diseases, childhood cancer and other paediatric health problems. The Paediatric Respiratory Epidemiology Group studies the epidemiology of frequent and rare respiratory disorders during childhood and over the life course. Main diseases of interest are asthma and other wheezing disorders, chronic cough, cystic fibrosis and primary ciliary dyskinesia. The group hosts the Leicester Respiratory Cohort Studies (www.leicestercohorts.org), the Swiss PCD Registry, the international PCD cohort (iPCD), the participatory project COVID-PCD (www.covid19pcd.ispm.ch/en), the Swiss Paediatric Asthma Cohort (SPAC; www.spac-study.ch) and the national database and surveillance of the Swiss Neonatal Screening for Cystic Fibrosis. Prof. Kuehni started her affiliation with the European Respiratory Society in 1993. She was secretary and head of the Paediatric Respiratory Epidemiology Group (7.6), core member of several task forces relating to PCD and asthma, and is a member of the ERS Scientific Committee and the Fellowships and Award Working group. For the ERJ she has been an Associate Editor since 2012 and paediatric Section Editor since 2018. |
|
Patrick Lévy |
Patrick Lévy, Professor of Physiology, MD, respiratory physician, graduated with a master’s degree in Animal Physiology (1986) and a PhD in Physiology (1989). He has been the head of the Hypoxia Pathophysiology Laboratory (HP2) Grenoble Alpes Univ. and Inserm (2003-2015) and established one of the most active research laboratories on obstructive sleep apnoea worldwide. He produced more than 400 international articles (H-index WOS 70, May 2022), being ranked within the top 10 of his scientific field worldwide (http://expertscape.com/ex/obstructive+sleep+apnea). He has been Rector of Grenoble Alpes University (Dec 2017 to Jan 2020) and previously of Joseph Fourier University in Grenoble (2012 to 2015), leading the project of Grenoble Alpes University – Initiative of Excellence, an ambitious vision for establishing a large research and multidisciplinary university in Grenoble and the Alps, reaching a critical mass and improving its international visibility. He has also been elected as European University Association Board Member (2019–2023). He is currently associate editor of the Journal of Sleep Research and section editor (sleep and ventilation) for the European Respiratory Journal. |
|
Giovanni Battista Migliori |
Giovanni Battista Migliori, MD, FRCP, FERS, FAPSR is Head of Clinical Epidemiology of the Respiratory Diseases Service and Director of the WHO Collaborating Centre for TB and Lung Diseases at Maugeri Care and Research Institute, Tradate, Italy. His major research interests are prevention, diagnosis, treatment and control of tuberculosis. He collaborates strictly with WHO and ECDC. He also provides clinical advice for M/XDR-TB cases. Former ERS Secretary General and President of the UNION (Europe Region), Prof. Migliori is Chief Editor of Int J Tuberc Lung Dis and was Associate Editor for the ERJ before his appointment as Section Editor in 2018. |
|
Paul O'Byrne |
Paul O'Byrne obtained his Medical Degree at University College, Dublin. He is currently the Dean and Vice President of the Faculty of Health Sciences at McMaster University. His research interests focus on the mechanisms and treatment of asthma. He has published more than 500 peer reviewed papers, and has an h-index (Google Scholar) of 120. His accolades include the James H. Graham Award of Merit of the Royal College of Physicians and Surgeons of Canada; election to the Royal Society of Canada; the European Respiratory Society Congress Award and Medal; election to the Canadian Academy of Health Sciences; and McMaster’s top academic award, Distinguished University Professor. In 2017, the American College of Chest Physicians named him a Giant of Chest Medicine and, more recently, he received an Honorary Life Achievement Award from the Ontario Thoracic Society, the Jack Hirsh Award for Outstanding Academic Achievement from McMaster University and Medical Graduate Distinguished Alumnus Award from University College, Dublin. |
|
Francesca Polverino |
Francesca Polverino, MD, PhD, is an associate professor of medicine with tenure at the Baylor College of Medicine, Houston, Texas. Her clinical and research interest is in chronic airway diseases and in particular COPD, with a background in lung immunology and pathology. After medical school, she completed a fellowship in immunology and lung pathology, to then moved to the Harvard Medical School, where she completed her PhD in pulmonary medicine and became a faculty member. She has been awarded several prestigious international recognitions, including the COPD Gold Medal by the European Respiratory Society, the Rising Star of Research Award from the American Thoracic Society, and the Medal of Honor for Scientific Merits from the Italian Prime Minister. She has received a total of $4.5 million funding for her studies in COPD, and serves on several study sections including for the NIH, American Lung Association and Department of Defense. |
|
José Manuel Porcel |
José Manuel Porcel, MD, FERS, FACP, FCCP, FEFIM, FAPSR, is Professor of Medicine, Chief of the Department of Internal Medicine, and Head of the Pleural Medicine Unit at the Arnau de Vilanova University Hospital in Lleida, Spain. He was Deputy Editor for Respirology and Chief Editor for Revista Clinica Española, and is currently Chief Editor for the Spanish Journal of Medicine and Associate Editor for ERJ Open Research. He has edited eight medical books, and authored over 450 peer reviewed papers and 90 book chapters. His clinical and research interests focus primarily on pleural diseases. |
Associate Editors
Esther Barreiro, Pompeu Fabra University, Spain
Chloe I. Bloom, Imperial College London, UK
Pierre-Régis Burgel, Université Paris Cité, France
Vincent Cottin, University of Lyon, France
Bruno Crestani, Université Paris-Diderot, France
Anh Tuan Dinh-Xuan, Université Paris-Descartes, France
David Gozal, University of Missouri-Columbia, USA
Christophe Guignabert, Université Paris-Saclay, France
Sergio Harari, Ospedale San Giuseppe, Italy
Paul Hassoun, Johns Hopkins University School of Medicine, USA
Pieter S. Hiemstra, Leiden University Medical Center, The Netherlands
Marius M. Hoeper, Hannover Medical School, Germany
John R. Hurst, University College London, UK
Yet Hong Khor, Austin Hospital Australia
Melanie Koenigshoff, University of Pittsburgh, USA
Stavros Konstantinides, Johannes Gutenberg University of Mainz, Germany
Tom Kotsimbos, Monash University, Australia
Wolfgang Kübler, Charite Universitatsmedizin, Germany
Marcus A. Mall, Charité – Universitätsmedizin Berlin, Germany
Silke Meiners, Research Center Borstel, Germany
Martin R. Miller, University of Birmingham, UK
Catherine W.M. Ong, National University of Singapore, Singapore
Hye Yun Park, Sungkyunkwan University, Republic of Korea
Laura C. Price, Royal Brompton Hospital, UK
Ganesh Raghu, University of Washington Medical Center, USA
Marcos I. Restrepo, UT Health San Antonio, USA
Renata L. Riha, University of Edinburgh, UK
Thomas Similowski, Université Pierre et Marie Curie, France
Jodie L. Simpson, Hunter Medical Research Institute, Australia
Dave Singh, University of Manchester, UK
Joan B. Soriano, Instituto de Investigación Hospital Universitario de la Princesa (IISP) Universidad Autónoma de Madrid, Spain
Daiana Stolz, University Hospital Basel, Switzerland
Louise V. Wain, University of Leicester, UK
Simon L.F. Walsh, King's College Hospital, UK
Jason Weatherald, University of Alberta, Canada
Tobias Welte, Hannover Medical School, Germany
Marlies Wijsenbeek, Erasmus University Medical Centre, The Netherlands
Roham Zamanian, Stanford University, USA
Disclosures of potential conflicts of interest made by the editors can be accessed through the links on the names listed above.
Statistics Editors
Xavier Basagaña, ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain
Pablo Martinez-Camblor, Dartmouth College, USA
Nicolas Molinari, University of Montpellier, France
Giovanni Sotgiu, University of Sassari, Italy
Xuekui Zhang, University of Victoria, Canada
Early Career Editors
Jonathan Baker, Imperial College London, UK
Vanesa Bellou, University of Ioannina Medical School, Greece
Thibaud Soumagne, European Hospital Georges Pompidou, Paris, France
Christina Thornton, University of Calgary, Canada
Zhaozhong Zhu, Harvard Medical School, USA
International Advisory Board
Alvar Agustí, Universitat de Barcelona, Spain
Peter J. Barnes, Imperial College London, UK
Eric D. Bateman, University of Cape Town, South Africa
Elisabeth H.D. Bel, University of Amsterdam, The Netherlands
Eric Berglund, Gothenburg, Sweden
Judith L. Black, University of Sydney, Australia
Francesco Blasi, Universita di Milano, Italy
Christopher Brightling, University of Leicester, UK
Laurent Brochard, University of Toronto, Canada
Guy Brusselle, Ghent University Hospital, Belgium
Peter M.A. Calverley, University Hospital Aintree, UK
Pascal Chanez, Université de la Méditerranée, France
Enrico M. Clini, Università degli Studi di Modena e Reggio Emilia, Italy
Ulrich Costabel, Ruhrlandklinik, Germany
Gerard J. Criner, Temple University School of Medicine, USA
Jeffrey M. Drazen, Harvard University, USA
Ratko Djukanovic, University of Southampton, UK
Stephen Durham, Imperial College London, UK
Oliver Eickelberg, Helmholtz Zentrum München, Germany
Leonardo M. Fabbri, Università degli Studi di Modena e Reggio Emilia, Italy
Jorrit Gerritsen, University Medical Center Groningen, The Netherlands
Loïc Guillevin, Université Paris-Descartes, France
Nick Hill, Tufts New England Medical Center, USA
Stephen Holgate, University of Southampton, UK
Meinhard Kneussl, Wilhelminenspital, Medical University of Vienna, Austria
Bart Lambrecht, University of Ghent, Belgium
Robert Loddenkemper, Deutsche Gesellschaft für Pneumologie, Germany
Joseph P. Lynch, University of California Los Angeles, USA
David M. Mannino, University of Kentucky College of Medicine, USA
Bradley A. Maron, Brigham and Women's Hospital, USA
Robert Naeije, Erasme University Hospital, Belgium
Benoit Nemery, Catholic University Leuven, Belgium
Laurent Nicod, Centre Hospitalier Universitaire Vaudois, Switzerland
Paolo Palange, Sapienza University of Rome, Italy
Ian Pavord, University of Oxford, UK
Michael I. Polkey, Royal Brompton Hospital, UK
Klaus F. Rabe, Krankenhaus Großhansdorf, Germany
Marlene Rabinovitch, Stanford University, USA
Helen K. Reddel, Woolcock Institute of Medical Research, Australia
Bruce K. Rubin, Virginia Commonwealth University School of Medicine, USA
Lewis J. Rubin, University of California San Diego, USA
Marina Saetta, Università degli Studi di Padova, Italy
Nikolaos M. Siafakas, University of Crete, Greece
Yves Sibille, Université Catholique de Louvain, Belgium
Anita K. Simonds, Royal Brompton Hospital, UK
Gérald Simonneau, Université Paris-Sud, France
Peter D. Sly, University of Queensland, Australia
Peter J. Sterk, University of Amsterdam, The Netherlands
Samy Suissa, McGill University, Canada
Wisia Wedzicha, Imperial College London, UK
Editorial Board Members
Past Chief Editors: J-C. Yernault†, Brussels, Belgium; E. Berglund, Gothenburg, Sweden; P. Vermeire†, Antwerp, Belgium; U. Costabel, Essen, Germany; M. Decramer, Leuven, Belgium; P.J. Sterk and K.F. Rabe, Amsterdam, the Netherlands and Kiel, Germany; A.T. Dinh-Xuan and V. Brusasco, Paris, France and Genoa, Italy; M. Humbert, Paris, France; M. Kolb, Hamilton, ON, Canada.
Publications office: 442 Glossop Road, Sheffield, S10 2PX, UK. Tel: +44 114 267 2860 Fax: +44 114 266 5064
Managing Editor: Neil Bullen, neil.bullen@ersnet.org
Director of Publications: Elin Reeves, elin.reeves@ersnet.org
Editorial Office Staff: Alice Bartlett, Clarissa Charles, Rachel Gozzard, Jonathan Hansen, Aimée Hill, Catherine Pumphrey, Matt Broadhead, Claire Marchant, Sarah Cleveland, Caroline Ashford-Bentley, Kay Sharpe, Kath Skinner.